PK-MERZ

This brand name is authorized in Austria, Croatia, Estonia, Hong Kong SAR China, Lithuania, Mexico, Turkey.

Active ingredients

The drug PK-MERZ contains one active pharmaceutical ingredient (API):

1	Amantadine UNII 9921T5P019 - AMANTADINE SULFATE
	Amantadine has been shown to be a low affinity antagonist at the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors. Overactivity of glutamatergic neurotransmission has been implicated in the generation of parkinsonian symptoms. In addition, amantadine specifically inhibits the replication of influenza A viruses at low concentrations.
	Read more about Amantadine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N04BB01	Amantadine	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BB Adamantane derivatives
Discover more medicines within N04BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1005185, 1005220, 1064472
HK	Department of Health Drug Office	27366
HR	Agencija za lijekove i medicinske proizvode	HR-H-688499731
LT	Valstybinė vaistų kontrolės tarnyba	1002865, 1026897, 1026898
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	027M2002, 260M2002
TR	İlaç ve Tıbbi Cihaz Kurumu	8699708010446, 8699708010453, 8699708010460, 8699708690525